Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. (2014)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(13)70172-4
PubMed Identifier: 25104632
Publication URI: http://europepmc.org/abstract/MED/25104632
Type: Journal Article/Review
Volume: 2
Parent Publication: The Lancet. Global health
Issue: 1
ISSN: 2214-109X